| Literature DB >> 25484578 |
Carina Wattmo1, Elisabet Londos1, Lennart Minthon1.
Abstract
INTRODUCTION: Many individuals with Alzheimer's disease (AD) live alone, and this figure is expected to increase. This study aimed to describe the cognitive and functional abilities of solitary-living AD patients, and the potential predictors of their usage of community-based services.Entities:
Keywords: activities of daily living; cognition; home-help services; living status; longitudinal study; nursing home placement
Mesh:
Substances:
Year: 2014 PMID: 25484578 PMCID: PMC4238751 DOI: 10.2147/CIA.S71709
Source DB: PubMed Journal: Clin Interv Aging ISSN: 1176-9092 Impact factor: 4.458
Demographic and clinical characteristics and endpoints according to living status (n=1,021)
| Variable | Solitary living (n=355; 35%) n/% | Living with a family member (n=666; 65%) n/% | |
|---|---|---|---|
| Female sex | 301/85% | 353/53% | <0.001 |
| Carrier of APOE ε4 allele (n=999) | 237/68% | 442/68% | 0.831 |
| Users of home-help services at baseline | 133/37% | 31/5% | <0.001 |
| Nursing home placement during the study | 122/34% | 110/17% | <0.001 |
| Deceased during the 3-year study | 54/15% | 81/12% | 0.175 |
| Completion rate after 3 years | 127/36% | 258/39% | 0.378 |
| Antihypertensives/cardiac therapy at baseline | 144/41% | 270/41% | 1.000 |
| Antidiabetics at baseline | 14/4% | 36/5% | 0.362 |
| NSAIDs/acetylsalicylic acid at baseline | 107/30% | 198/30% | 0.886 |
| Lipid-lowering agents at baseline | 29/8% | 89/13% | 0.014 |
| Antidepressants at baseline | 113/32% | 144/22% | <0.001 |
| Antipsychotics at baseline | 28/8% | 19/3% | <0.001 |
| Anxiolytics/sedatives/hypnotics at baseline | 62/17% | 86/13% | 0.051 |
| Estimated age at onset, years | 74.0±7.0 (48–87) | 71.2±7.3 (45–88) | <0.001 |
| Age at first assessment, years | 77.1±6.4 (52–88) | 74.2±7.1 (47–88) | <0.001 |
| Education, years | 9.3±2.4 (7–17) | 9.5±2.6 (7–17) | 0.105 |
| MMSE score at baseline | 21.4±3.7 (10–26) | 21.4±3.7 (10–26) | 0.891 |
| IADL score at baseline | 15.7±5.4 (8–28) | 16.1±5.5 (8–31) | 0.345 |
| PSMS score at baseline | 7.8±2.6 (6–21) | 7.3±2.1 (6–20) | 0.002 |
| Number of medications used at baseline | 3.2±2.7 (0–17) | 2.8±2.2 (0–12) | 0.006 |
| Home-help services at baseline, hours/week (n=164) | 5.7±4.4 (0.5–21.0) | 4.8±6.2 (0.5–25.0) | 0.471 |
| Length in the SATS, months | 22.2±13.5 (1–36) | 23.7±12.7 (1–36) | 0.074 |
| Time to nursing home placement from baseline, months (n=232) | 17.3±10.7 (0–36) | 22.2±8.4 (2–36) | <0.001 |
| Mean dose of ChEI during the follow-up period, mg/day | |||
| Donepezil (n=518) | 6.8±1.8 (2.8–9.4) | 7.0±1.7 (2.8–9.4) | 0.210 |
| Rivastigmine (n=212) | 6.2±2.2 (2.5–10.5) | 6.1±2.1 (2.3–10.5) | 0.708 |
| Galantamine (n=291) | 14.7±3.5 (8.0–22.0) | 15.4±3.8 (8.0–22.0) | 0.100 |
Abbreviations: n, number; APOE, apolipoprotein E; NSAIDs, nonsteroidal anti-inflammatory drugs; SD, standard deviation; MMSE, Mini-Mental State Examination; IADL, Instrumental Activities of Daily Living scale; PSMS, Physical Self-Maintenance Scale; SATS, Swedish Alzheimer Treatment Study; ChEI, cholinesterase inhibitor.
Figure 1The percentage of AD patients who need help carrying out IADL and basic ADL tasks at baseline according to living status.
Notes: (A) The percentage of AD patients (n=1,021) who needed help to carry out IADL tasks (IADL score: 2–5) at the start of ChEI therapy (baseline) according to living status (***P<0.001; **0.001≤P<0.01). (B) The percentage of patients (n=1,021) who needed help to carry out basic ADL tasks (PSMS score: 2–5) at baseline according to living status (***P<0.001; **0.001≤P<0.01; *P<0.05).
Abbreviations: AD, Alzheimer’s disease; IADL, Instrumental Activities of Daily Living scale; ADL, activities of daily living; n, number; ChEI, cholinesterase inhibitor; PSMS, Physical Self-Maintenance Scale.
Binary logistic regression analysis of the presence of home-help services at baseline
| Percent correctly classified | Solitary living (n=355)
| Living with a family member (n=666)
| ||
|---|---|---|---|---|
| 79.7%
| 95.7%
| |||
| Odds ratio (95% CI) | Odds ratio (95% CI) | |||
| Sex (male =0; female =1) | NS | 3.01 (1.23–7.36) | 0.016 | |
| Age at first assessment, years | NS | 1.12 (1.03–1.22) | 0.007 | |
| IADL score at baseline | 1.34 (1.25–1.43) | <0.001 | NS | |
| PSMS score at baseline | NS | 1.46 (1.28–1.68) | <0.001 | |
| Number of medications used at baseline | 1.20 (1.08–1.33) | <0.001 | 1.18 (1.02–1.37) | 0.030 |
Notes: Apolipoprotein E genotype, years of education, Mini-Mental State Examination score at baseline, and specific concomitant medications (antihypertensive/cardiac therapy, antidiabetics, nonsteroidal anti-inflammatory drugs/acetylsalicylic acid, lipid-lowering agents, antidepressants, antipsychotics, and anxiolytics/sedatives/hypnotics) used at baseline were not significant factors in the models. The odds ratios are expressed per 1 unit increase for continuous variables and for the condition present for categorized variables.
Abbreviations: n, number; CI, confidence interval; NS, not significant; IADL, Instrumental Activities of Daily Living scale; PSMS, Physical Self-Maintenance Scale.
Demographic and clinical characteristics according to living status after 3 years of ChEI treatment (n=376)
| Variable | Solitary living (n=108; 29%)
| Living with a family member (n=213; 57%)
| Nursing home (n=55; 15%)
| |
|---|---|---|---|---|
| n/% | n/% | n/% | ||
| Female sex | 87/81% | 113/53% | 44/80% | <0.001 (<0.001) |
| Users of home-help services | 77/71% | 25/12% | NA | <0.001 |
| Age, years | 80.5±6.0 (57–91) | 76.4±7.4 (50–90) | 79.8±6.3 (56–90) | <0.001 (<0.001) |
| MMSE score | 20.6±5.2 (6–29) | 19.6±6.3 (0–29) | 13.8±5.7 (0–25) | <0.001 (0.471) |
| IADL score | 20.8±6.1 (8–30) | 19.6±6.4 (8–31) | 28.0±2.5 (20–31) | <0.001 (0.308) |
| PSMS score | 10.0±3.9 (6–22) | 9.0±3.2 (6–22) | 13.7±4.0 (7–22) | <0.001 (0.049) |
| Home-help services, hours/week (n=102) | 9.2±6.6 (1.0–35.0) | 5.1±5.2 (0.5–20.0) | NA | 0.005 |
Note:
The comparison between solitary-living patients and those living with family is presented as P-values with the Bonferroni correction in parentheses.
Abbreviations: ChEI, cholinesterase inhibitor; n, number; NA, not applicable; SD, standard deviation; MMSE, Mini-Mental State Examination; IADL, Instrumental Activities of Daily Living scale; PSMS, Physical Self-Maintenance Scale.
Figure 2The percentage of AD patients who needed help to carry out IADL and basic ADL tasks after 3 years of ChEI therapy according to living status.
Notes: (A) The percentage of AD patients (n=376) who needed help to carry out IADL tasks (IADL score: 2–5) after 3 years of ChEI therapy according to living status (***P<0.001; **0.001≤P<0.01; *P<0.05; the comparison between solitary-living patients and those living with family was corrected [Bonferroni] and is presented in parentheses). (B) The percentage of patients (n=376) who needed help to carry out basic ADL tasks (PSMS score: 2–5) after 3 years of ChEI therapy according to living status (***P<0.001; **0.001≤P<0.01; *P<0.05; the comparison between solitary-living patients and those living with family was corrected [Bonferroni] and is presented in parentheses).
Abbreviations: AD, Alzheimer’s disease; IADL, Instrumental Activities of Daily Living scale; ADL, activities of daily living; ChEI, cholinesterase inhibitor; n, number; PSMS, Physical Self-Maintenance Scale.
Binary logistic regression analysis of nursing home placement during the study
| Percent correctly classified | Solitary living at baseline (n=355)
| Living with a family member at baseline (n=666)
| ||
|---|---|---|---|---|
| 64.6%
| 82.9%
| |||
| Odds ratio (95% CI) | Odds ratio (95% CI) | |||
| Sex (male =0, female =1) | NS | 1.89 (1.18–3.02) | 0.008 | |
| IADL score at baseline | 1.10 (1.05–1.15) | <0.001 | 1.15 (1.10–1.20) | <0.001 |
| IADL score, rate of change per month | 0.41 (0.17–0.97) | 0.043 | 0.21 (0.10–0.45) | <0.001 |
| Home-help services, hours/week at the last assessment prior to nursing home entry | NS | 1.07 (1.02–1.12) | 0.007 | |
Notes: Apolipoprotein E genotype, age at baseline, years of education, and MMSE and PSMS scores at baseline, or their rates of change per month, were not significant factors in the models. Odds ratios are expressed per 1 unit increase for continuous variables and for the condition present for categorized variables.
Abbreviations: n, number; CI, confidence interval; NS, not significant; IADL, Instrumental Activities of Daily Living scale; MMSE, Mini-Mental State Examination; PSMS, Physical Self-Maintenance Scale.